Moolec Science
MLEC
2 hedge funds and large institutions have $36.6K invested in Moolec Science in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
11% less capital invested
Capital invested by funds: $41.2K → $36.6K (-$4.67K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$129 |
| 2 |
EC
Elequin Capital
New York
|
-$3 |
MLEC Hedge Fund Activity: Q4 2023 in Review
2 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Moolec Science (MLEC) for Q4 2023, worth a combined $36.6K — down 11% from $41.2K a quarter earlier.
Fund positioning in MLEC was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.95K. The largest seller was UBS Group, cutting an estimated $129.
- 2 institutional investors held Moolec Science (MLEC) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $36.6K of Moolec Science stock for Q4 2023, down 11% quarter-over-quarter.
- 0 funds opened new Moolec Science positions in Q4 2023 and 0 closed out.
- The largest Moolec Science buyer in Q4 2023 was Morgan Stanley, an estimated $1.95K added.
- The largest Moolec Science seller in Q4 2023 was UBS Group, an estimated $129 sold.
Based on aggregated 13F filings for Q4 2023.